Kura Oncology Announces Three Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
<p>– Presentations to highlight preclinical data supporting combination of KO-2806 with targeted therapies, including TKIs, KRASG12C inhibitors and KRASG12D inhibitors – SAN DIEGO, Oct. 04, 2023 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer, today announced that three […]</p>
<p>The post <a rel="nofollow" href="https://forextv.com/top-news/kura-oncology-announces-three-presentations-at-aacr-nci-eortc-international-conference-on-molecular-targets-and-cancer-therapeutics/">Kura Oncology Announces Three Presentations at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics</a> appeared first on <a rel="nofollow" href="https://forextv.com">ForexTV</a>.</p>
Leave a Comment